Examples of using Paediatric studies in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Paediatric studies.
A publicly available database of paediatric studies.
Paediatric studies with Sycrest were performed using flavoured sublingual tablets.
Summary of Steady-state AUC24 of nelfinavir in Paediatric Studies.
Which paediatric studies had to be submitted by 26 January 2008 and which conditions had to be met?
Table 1 Fluenz Efficacy in Placebo Controlled Paediatric Studies.
Pharmaceutical companies that carry out paediatric studies can be granted a six-month extension to a supplementary protection certificate that has already been granted or.
The efficacy and safety of basiliximab were evaluated in two paediatric studies.
Table 2 T/LAIV relative efficacy in active-controlled paediatric studies with seasonal injectable influenza vaccine.
Assessment of adverse reactionsis based on data from three studies in adults(n=1,479) and three paediatric studies n=169.
Adverse drug reactions(ADRs) reported in the prophylactic paediatric studies were similar in the placebo and palivizumab groups.
Glycerol phenylbutyrate was found to be non-inferior to sodium phenylbutyrate with respect to ammonia control in both of these paediatric studies.
Additional adverse reactions observed in paediatric studies aged 1to 17 years.
Assessment of adverse reactions from clinical study data isbased on experience in three studies in adults(n 1,479) and three paediatric studies n 169.
The paper also proposes an obligation for companies to perform paediatric studies as a marketing authorisation requirement, unless the medicine is unlikely to be used for children.
In three paediatric studies, treatment-naïve(n=123) and treatment-experienced(n=46)paediatric patients aged 4 months to 18 years were treated with emtricitabine in combination with other antiretroviral agents.
EURORDIS has actively participated in the designation of over 1200 orphanmedicines to date, including protocol assistance, paediatric studies, and overall clinical development up to marketing authorisation.
Pharmaceutical companies that carry out paediatric studies can be granted a six-month extension to a supplementary protection certificate that has already been granted or granted a newly created paediatric supplementary protection certificate.
However, Article 36, in relation to Article 29, provides that the extension of the supplementary protectioncertificate is only granted if information on the paediatric studies conducted is included in the product information when an authorisation is granted.
No paediatric studies, as referred to in paragraph 1, which have at the date of entry into force of this Regulation already been submitted for assessment in a third country, shall be taken into consideration for the rewards and incentives provided for in Articles 36, 37 and 38.
Article 44 in the amended proposal was renumbered as 45 in the common position and modified to clarify that it is theMarketing Authorisation Holder that should submit any paediatric studies already completed, to clarify the competent authorities' role in updating product information.
Within one year of the entry into force of this Regulation, any paediatric studies already completed, by the date of entry into force, in respect of products authorised in the Community shall be submitted for assessment to the competent authority.
All existing paediatric studies, as referred to in paragraph 1, shall be taken into consideration by the Paediatric Committee when assessing applications for paediatric investigation plans, waivers and deferrals and by competent authorities when assessing applications submitted pursuant to Articles 8, 9 or 31.
Amendment 43(1st and 2nd part) clarifying that the results of all paediatric studies should be included in the summary of the product characteristics and, where the information is of use to patients, in the package leaflet, with some rewording.
Amendment 69 on the eligibility of paediatric studies initiated prior to entry into force to be included in a paediatric investigation plan is redundant since the Commission has accepted amendment 62 which deals with the same situation.
In a phase 1 study(see section 5.1), using a 10 mg/ml solution for subcutaneous injection specifically developed for the paediatric studies, the mean maximum blood concentrations(Cmax) were 243 ng/ml in the 2 to< 6-year group, 255 ng/ml in the 6 to< 12-year group and 224 ng/ml in the 12 to< 18-year group after a single subcutaneous injection of 100 μg/kg(maximum 6 mg) lipegfilgrastim with the first cycle of chemotherapy.
In view of the time and resources required for paediatric studies as well as sensitive ethical and compliance issues relating to paediatric patients, the EESC agrees with the proposal to set up a system of incentives and rewards but would suggest strengthening them in certain specific situations.
The adverse reactions profile seen in this paediatric study was generally consistent with that in adults see table above.
In the paediatric study, the most prevalent adverse reactions in patients treated with combination therapy for up to 48 weeks with Pegasys and ribavirin were influenza-like illness(91%), headache(64%), gastrointestinal disorder(56%),, and injection-site reaction 45.